Muscle-specific miRNAs in plasma and skeletal muscle of patients with idiopathic inflammatory myopathy are modulated by disease and training
Authors:
- Nikoleta Alchus LaiferováNLNikoleta Alchus Laiferová
- Lucia VernerováLVLucia Vernerová
- Michal NemecMNMichal Nemec
- Daria BarkovaDBDaria Barkova
- Katarína RerkováKRKatarína Rerková
- Karin Marček MalenovskáKMKarin Marček Malenovská
- Martina VokurkováMVMartina Vokurková
- Sabína OreskáSOSabína Oreská
- Martin KleinMKMartin Klein
- Maja ŠpiritovićMŠMaja Špiritović
- Michal TomčíkMichal Tomčík
- Jozef UkropecJUJozef Ukropec
- 7 January 2025
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (7) , 4347-4356
Abstract
Objective: The objective of this work was to examine myomiR levels in plasma, skeletal muscle, and skeletal muscle cells of patients with idiopathic inflammatory myopathy (IIM), and their interrelations with the disease-related clinical phenotypes and with the effects of a disease-modifying 6-months-training intervention. Methods: Samples of vastus lateralis muscle (n = 12/13) and plasma (n = 21/20) were obtained from IIM patients and healthy controls, respectively. The muscle and plasma samples were obtained before and after a 6-months training intervention in 7 patients. MyomiRs miR-1, -206, -133a, and -133b were quantified using quantitative PCR (qPCR). The effects of pro-inflammatory (TNF) and metabolic (glucose, insulin) systemic factors and of immunosuppressive therapy (dexamethasone) on the myomiRs were examined in muscle cells in vitro. Results: MiR-133b was lower in the skeletal muscle of IIM patients than in that of healthy controls (P = 0.03). The levels of miR-133a, miR-1, and miR-206 were not regulated. Moreover, the plasma levels of miR-133b and miR-1 were reduced in patients with IIM compared with those in healthy controls (P <0.05). It was observed that exercise induced reciprocal regulation of specific myomiRs in the muscle and plasma of patients with IIM: it lowered miR-133b in muscle while increasing miR-133b and miR-206 in plasma. Treatment of myotubes with TNF, insulin, glucose and dexamethasone (individually) induced the downregulation of distinct myomiRs. Conclusion: Lower myomiR levels in the skeletal muscle of IIM patients might indicate reduced muscle regenerative potential in IIM, which could be linked to inflammation, metabolic dysfunction, and immunosuppressive therapy. Training-induced changes in muscle and plasma myomiRs indicate an increase in the release of myomiRs, which could contribute to the adaptive response underlying the positive systemic effects of exercise in IIM. Trial registration: ISRCTN register, https://www.isrctn.com/ ISRCTN35925199.Keywords
Funding Information
- Ministry of Health of the Czech Republic (023728, NU21-05–00322, NU21-01–00146)
- Ministry of Education, Youth and Sports
- Czech Republic (BBMRI.cz-LM2023033)
- Slovak Research and Development Agency (APVV20/0466)
- Agency of the Slovak Academy of Sciences (VEGA-2/0076/22)
This publication has 44 references indexed in Scilit:
- Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatmentsCell Metabolism, 2024
- Sarcopenia is associated with hypomethylation of TWEAK and increased plasma levels of TWEAK and its downstream inflammatory factor TNF-α in older adults: A case-control studyExperimental Gerontology, 2024
- Influence of microRNAs and exosomes in muscle health and diseasesJournal of Muscle Research and Cell Motility, 2019
- Exercise in MyositisCurrent Treatment Options in Rheumatology, 2018
- Current Treatment for MyositisCurrent Treatment Options in Rheumatology, 2018
- Roles and clinical implications of microRNAs in acute lymphoblastic leukemiaJournal of Cellular Physiology, 2017
- New Insights into the Benefits of Exercise for Muscle Health in Patients with Idiopathic Inflammatory MyositisCurrent Rheumatology Reports, 2014
- Current understanding of sarcopenia: possible candidates modulating muscle massPflügers Archiv - European Journal of Physiology, 2014
- Inhibition of Myogenic MicroRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory MyopathiesArthritis & Rheumatology, 2013
- MicroRNA-206: The skeletal muscle-specific myomiRBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2008